RedditKon
Joined 12 years ago
Joined 12 years ago
• Exenatide - FDA approved in 2005
• Liraglutide / Saxenda - FDA approved in 2010
• Dulaglutide / Trulicity - FDA approved in 2014
• Semaglutide / Ozempic/Wegovy - FDA approved in 2017
• Tirzepatide / Mounjaro - FDA approved in 2022
Ozempic / Semaglutide was FDA approved in 2017, but clinical trials started in 2008. That was 16 years ago. Obviously it's always possible there are even longer term side effects we're unaware of, but generally if this class of drug caused large scale problems for kidneys, liver, etc, we'd likely know by now.
Last I heard they have $1B in cash on hand and are doing roughly $3B/year in revenue. Musk has reportedly gotten their annual expenses down to $3B with another $1.5B in annual debt servicing costs.
By my math that's less than a year of runway.
It only works if all the companies agree to cover it.
Mounjaro is not widely available outside the US yet.
Disclaimer: I’m not advocating this - just sharing info.
That's pretty substantial. Obviously no one knows what Phase 3 will show, but cynicism seems unwarranted at this point.
https://investor.lilly.com/news-releases/news-release-detail...